Asset
Meloxicam
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01436032 | phase3 | terminated | 2011-10-01 | 2012-03-01 | Alkermes, Inc. | Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery |
| NCT00945763 | phase2 | completed | 2009-07-01 | 2009-11-01 | Alkermes, Inc. | Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery |
| NCT01084161 | phase2 | completed | 2010-03-01 | 2011-01-01 | Alkermes, Inc. | Study to Evaluate the Efficacy, Safety and Tolerability of N1539 |
FDA applications (0)
This company has no applications containing this asset.